A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/12 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2527881
The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides. Furthermore, the present invention provides the use of an MC3R agonist peptide for the manufacture of a medicament for the treatment of metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, inducing weight loss and increasing muscle mass in a patient.
La présente invention concerne des méthodes consistant à administrer des peptides agonistes de MC3R pour le traitement de troubles du métabolisme, dont l'obésité, le diabète sucré, la cachexie, la sarcopénie et les troubles cardio-vasculaires, des techniques propres à induire une perte de poids ou à augmenter la masse musculaire chez un patient. De plus, cette invention préconise l'utilisation d'un peptide agoniste de MC3R pour le traitement des troubles du métabolisme susmentionnés ainsi que pour induire une perte de poids ou une augmentation de la masse musculaire chez un patient.
Gadski Robert Alan
Heiman Mark Louis
Hsiung Hansen Maxwell
Mayer John Philip
Yan Lian Zeng
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Uses of melanocortin-3 receptor (mc3r) agonist peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of melanocortin-3 receptor (mc3r) agonist peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of melanocortin-3 receptor (mc3r) agonist peptides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1749750